Skip to content

A Consensus on Opioid Prescription for Oncologic Patients in Latin America - A DELPHI Study.

A Consensus on Opioid Prescription for Oncologic Patients in Latin America - A DELPHI Study.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04844788
Enrollment
20
Registered
2021-04-14
Start date
2021-04-15
Completion date
2021-06-30
Last updated
2021-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Patients, Cancer-related Pain

Keywords

opioids, cancer-related pain, end-of-life, opioid abuse

Brief summary

As seen worldwide, cancer incidence is increasing in Latin America achieving an amount of 1.3 million new cases annually.1 In addition, it is expected that up to 70% of patients with cancer will experience pain2, one of the most distressing symptoms in patients with advanced cancer. And despite of advances in cancer therapies, opioids remain the mainstay treatment of cancer-related moderate-to-severe and end-of-life pain.3 However, concerns regarding opioid prescriptions have emerged for reasons like the risk of misuse and the possibility of cancer progression. In the last decades, an increase in consumption of opioids as well as in opioids-related deaths generating the so called 'opioid crisis'. This rise is mainly due to abuse / addiction of opioids. Consequently, oncologic patients are at risk for abuse, as well as for aberrant use, which can complicate the course of cancer treatment.4 5 Another feature of opioids use in cancer patients is that it may contribute to disease progression. Experimental studies suggest that opioids can may lead to immunosuppression and tumor progression or recurrence.6-8 On the other hand, retrospective analysis of clinical data shows conflicting results and trials are lacking.

Interventions

None listed

Sponsors

Instituto do Cancer do Estado de São Paulo
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Head of anesthesia, Pain management and palliative care departments of cancer hospitals in Latin America.

Exclusion criteria

* Surveys not answered.

Design outcomes

Primary

MeasureTime frameDescription
Survey answersUp to 3 (three) monthsanswers of the survey sent

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026